Search
Akero Therapeutics Inc
AKROAdd to Watchlist
54.650USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
4.50BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Wed, Apr 29
Updated: Wed, Apr 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cheng (Andrew)
0.37%
Rolph (Timothy Peter)
0.29%
Harrison (Seth Loring)
0.17%
Grantham Mayo Van Otterloo & Co LLC
0.14%
Walmsley (Graham G)
0.11%
Other
98.92%
Shareholders
Shareholders
Proportion
Cheng (Andrew)
0.37%
Rolph (Timothy Peter)
0.29%
Harrison (Seth Loring)
0.17%
Grantham Mayo Van Otterloo & Co LLC
0.14%
Walmsley (Graham G)
0.11%
Other
98.92%
Shareholder Types
Shareholders
Proportion
Individual Investor
1.08%
Investment Advisor
0.32%
Investment Advisor/Hedge Fund
0.24%
Bank and Trust
0.01%
Other
98.35%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
499
491.95K
0.60%
-100.92M
2025Q4
504
92.63M
123.44%
-26.38K
2025Q3
532
92.72M
128.44%
-619.25K
2025Q2
513
93.19M
122.60%
+5.80M
2025Q1
481
87.41M
107.62%
+1.72M
2024Q4
438
74.28M
124.07%
+570.22K
2024Q3
432
73.67M
126.17%
-695.38K
2024Q2
416
72.42M
128.65%
-3.01M
2024Q1
408
73.91M
107.89%
+1.88M
2023Q4
389
59.72M
117.03%
+1.94M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Cheng (Andrew)
304.10K
0.37%
-89.28K
-22.69%
Nov 20, 2025
Rolph (Timothy Peter)
236.46K
0.29%
+115.58K
+95.62%
Nov 25, 2025
Harrison (Seth Loring)
138.66K
0.17%
-145.70K
-51.24%
Dec 09, 2025
Grantham Mayo Van Otterloo & Co LLC
117.61K
0.14%
-47.45K
-28.75%
Dec 31, 2025
Walmsley (Graham G)
93.00K
0.11%
+90.83K
+4189.67%
Oct 22, 2025
Pictet Asset Management (Japan) Ltd.
64.03K
0.08%
+64.03K
--
Oct 31, 2025
UBS Fund Management (Switzerland) AG
41.23K
0.05%
-1.54K
-3.61%
Jun 30, 2025
Harvest Fund Management Co., Ltd.
40.30K
0.05%
+21.18K
+110.81%
Jun 30, 2025
Yale (Catriona)
35.53K
0.04%
+8.27K
+30.32%
Nov 04, 2025
T. Rowe Price Japan, Inc.
30.90K
0.04%
-3.30K
-9.64%
Apr 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Simplify Propel Opportunities ETF
11.66%
ProShares Merger ETF
2.71%
State Street SPDR S&P Biotech ETF
1.78%
ALPS Medical Breakthroughs ETF
1.75%
AltShares Merger Arbitrage ETF
1.63%
Direxion Daily S&P Biotech Bull 3X Shares
1.1%
ProShares Ultra Nasdaq Biotechnology
0.43%
Invesco Nasdaq Biotechnology ETF
0.42%
iShares Biotechnology ETF
0.34%
Pacer WealthShield ETF
0.28%
View more
Simplify Propel Opportunities ETF
Proportion11.66%
ProShares Merger ETF
Proportion2.71%
State Street SPDR S&P Biotech ETF
Proportion1.78%
ALPS Medical Breakthroughs ETF
Proportion1.75%
AltShares Merger Arbitrage ETF
Proportion1.63%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion1.1%
ProShares Ultra Nasdaq Biotechnology
Proportion0.43%
Invesco Nasdaq Biotechnology ETF
Proportion0.42%
iShares Biotechnology ETF
Proportion0.34%
Pacer WealthShield ETF
Proportion0.28%
